[D2] Spotlight Session: Obstacles to Ending the HIV Epidemic: Risk and Burden of Suboptimal Care in People Living with HIV

Pricing: Free for Members and Non-Members

*Continuing Pharmacy Education credit is not available for this course.

This session is sponsored by Gilead. 

Course Description

This educational session will highlight the potential quality of care initiatives toward HIV treatment, a public health priority. Epidemiological data from the Centers for Disease Control and Prevention (CDC) will be reviewed to describe the HIV epidemic in the United States including communities disproportionately affected. The interplay of social determinants of health and the health disparities they create in vulnerable populations of PLWH will be discussed. Clinical and economic consequences of suboptimal care in PLWH will be described. Potential managed care/clinical initiatives will be reviewed.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Describe the burden of illness in people living with HIV (PLWH) with consideration to the current epidemiological landscape data from the CDC.
  2. Understand how social determinants of health create disparities in vulnerable populations of PLWH.
  3. Describe the select clinical and economic consequences of suboptimal care in PLWH.
  4. Gain new perspectives on the role of managed care in maintaining high-quality care opportunities through education and patient engagement programs, and other ways to address suboptimal care.
Course summary
Available credit: 
  • 1.25 Certificate of Completion
Course opens: 
11/15/2023
Course expires: 
12/31/2024
Cost:
$0.00

Faculty

Diana Brixner, RPh, PhD, FAMCP
Professor, Pharmacotherapy
Executive Director
Pharmacotherapy Outcomes Research Center
University of Utah

Omar Daoud, PharmD
Senior Director of Pharmacy
Community Health Plan of Washington

Jay Gladstein, MD
Chief Medical Officer & Site Medical Director
APLA Health Center
Assistant Clinical Professor
UCLA School of Medicine

Marcus Wilson
Senior Director for Community Engagement and Patient Advocacy, U.S. Virology
Gilead Sciences, Inc.

Moderator

Diana Brixner, RPh, PhD, FAMCP
Professor, Pharmacotherapy
Executive Director
Pharmacotherapy Outcomes Research Center
University of Utah

Financial Relationship Disclosures

Faculty/Reviewer/PlannerReported Relevant Financial Relationships
Diana Brixner
Faculty		Diana Brixner reports the Pharmacotherapy Outcomes Research Center at the University of Utah has received research grants from Gilead Sciences, Inc.
Omar Daoud
Faculty		Disclosed no relevant financial relationships.​
Jay Gladstein
Faculty		Jay Gladstein participates in the speakers’ bureau for Gilead Sciences, Inc. and Viiv Healthcare.
Marcus Wilson
Faculty		Marcus Wilson is an employee of Gilead Sciences, Inc.
  • AMCP Staff have disclosed no relevant financial relationships.
  • If applicable, relevant financial relationships have been mitigated and documented.
  • Content has undergone a peer review to ensure content validity.

Available Credit

  • 1.25 Certificate of Completion

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities